Molecular techniques for the personalised management of patients with chronic myeloid leukaemia

by Mary Alikian, Robert Peter Gale, Jane F Apperley, Letizia Foroni
Published 2017-03-01

JACIE Accreditation in 2008

by Derwood Pamphilon, Jane F. Apperley, Diana Samson, Ineke Slaper-Cortenbach, Eoin McGrath
Published 2009-04-01

Management of adverse events associated with bosutinib treatment of chronic-phase chronic myeloid leukemia: expert panel review

by Jorge E. Cortes, Jane F. Apperley, Daniel J. DeAngelo, Michael W. Deininger, Vamsi K. Kota, Philippe Rousselot, Carlo Gambacorti-Passerini
Published 2018-12-01

Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors

by Bryant Boulianne, Mark E. Robinson, Philippa C. May, Leandro Castellano, Kevin Blighe, Jennifer Thomas, Alistair Reid, Markus Müschen, Jane F. Apperley, Justin Stebbing, Niklas Feldhahn
Published 2017-02-01

Validation of CIP2A as a Biomarker of Subsequent Disease Progression and Treatment Failure in Chronic Myeloid Leukaemia

by Richard E. Clark, Ammar A. Basabrain, Gemma M. Austin, Alison K. Holcroft, Sandra Loaiza, Jane F. Apperley, Christopher Law, Laura Scott, Alexandra D. Parry, Laura Bonnett, Claire M. Lucas
Published 2021-04-01

Combined inhibition of p97 and the proteasome causes lethal disruption of the secretory apparatus in multiple myeloma cells.

by Holger W Auner, Anne Marie Moody, Theresa H Ward, Marianne Kraus, Enrico Milan, Philippa May, Aristeidis Chaidos, Christoph Driessen, Simone Cenci, Francesco Dazzi, Amin Rahemtulla, Jane F Apperley, Anastasios Karadimitris, Niall Dillon
Published 2013-01-01

Cost and quality issues in establishing hematopoietic cell transplant program in developing countries

by Shahrukh K. Hashmi, Alok Srivastava, Walid Rasheed, Salman Adil, Tong Wu, Madan Jagasia, Amr Nassar, William Y.K. Hwang, Amir Ali Hamidieh, Hildegard T. Greinix, Marcelo C. Pasquini, Jane F. Apperley, Mahmoud Aljurf
Published 2017-12-01

Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease

by Ahmad Khoder, Abdullah Alsuliman, Rafet Basar, Catherine Sobieski, Kayo Kondo, Amin Majid Alousi, Richard Szydlo, Muharrem Muftuoglu, Hila Shaim, Jane F. Apperley, Elif Gokdemir, Nichola Cooper, Rohtesh S. Mehta, David Marin, Richard Champlin, Elizabeth Shpall, Katayoun Rezvani
Published 2018-01-01

Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation

by Andrew J. Innes, Benjamin H. Mullish, Rohma Ghani, Richard M. Szydlo, Jane F. Apperley, Eduardo Olavarria, Renuka Palanicawandar, Edward J. Kanfer, Dragana Milojkovic, Julie A. K. McDonald, Eimear T. Brannigan, Mark R. Thursz, Horace R. T. Williams, Frances J. Davies, Julian R. Marchesi, Jiří Pavlů
Published 2021-08-01

Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines

by George Q. Daley, Insoo Hyun, Jane F. Apperley, Roger A. Barker, Nissim Benvenisty, Annelien L. Bredenoord, Christopher K. Breuer, Timothy Caulfield, Marcelle I. Cedars, Joyce Frey-Vasconcells, Helen E. Heslop, Ying Jin, Richard T. Lee, Christopher McCabe, Megan Munsie, Charles E. Murry, Steven Piantadosi, Mahendra Rao, Heather M. Rooke, Douglas Sipp, Lorenz Studer, Jeremy Sugarman, Masayo Takahashi, Mark Zimmerman, Jonathan Kimmelman
Published 2016-06-01

Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3

by Laura Tornatore, Daria Capece, Daniel D'Andrea, Federica Begalli, Daniela Verzella, Jason Bennett, Gary Acton, Elizabeth A. Campbell, James Kelly, Michael Tarbit, Nigel Adams, Selina Bannoo, Antonio Leonardi, Annamaria Sandomenico, Domenico Raimondo, Menotti Ruvo, Angela Chambery, Metod Oblak, Magda J. Al-Obaidi, Richard S. Kaczmarski, Ian Gabriel, Heather E. Oakervee, Martin F. Kaiser, Ashutosh Wechalekar, Reuben Benjamin, Jane F. Apperley, Holger W. Auner, Guido Franzoso
Published 2019-01-01